Braveheart Bio Quarterly Cash Flow Statement
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
20.02+0.93 (+4.87%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Braveheart Bio cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q? 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | -14.99M | -14.28M | -381.00K | -99.00K |
| Net Income growth (YoY) | — | — | — | — |
This table shows 4 quarterly periods of Braveheart Bio's cash flow statement, from Q2 2026 back to Q? 2025, across 1 line items including net income. Values in USD; B = billions, M = millions. Fiscal periods follow BRVE's reporting calendar. What is a cash flow statement?